Presentation Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD April 25, 2017
News Daily News Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR Shelley Wood April 24, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017
News Daily News Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes Todd Neale December 12, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
News Daily News Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction Michael O'Riordan July 20, 2016
News Daily News Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib Todd Neale June 27, 2016
News Daily News Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs Todd Neale January 20, 2016
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015